Intermittent Fasting Protocols: Optimising Metabolic Flexibility in the Modern British Lifestyle

Overview

Modern metabolic physiology is currently grappling with a profound evolutionary mismatch. The contemporary British lifestyle—characterised by ubiquitous access to ultra-processed foods, sedentary office environments, and a persistent circadian disruption driven by artificial illumination—has structurally locked the human organism into a state of chronic carbohydrate dependency. Historically, Homo sapiens evolved under conditions of nutritional scarcity, necessitating a metabolic machinery capable of seamlessly transitioning between exogenous fuel utilisation and endogenous fat oxidation. This physiological capacity, formally defined as metabolic flexibility, has been severely eroded by the standard British dietary paradigm, which typically involves grazing from early morning until late evening. At INNERSTANDIN, our exhaustive analysis of the current literature indexed on PubMed and evaluated within publications such as The Lancet reveals that this continuous postprandial state chronically suppresses foundational cellular repair mechanisms, most notably macroautophagy.

Intermittent fasting (IF) protocols are not merely behavioural weight-management fads; they represent targeted therapeutic interventions designed to re-engage ancient, conserved evolutionary pathways. By systematically restricting the feeding window—whether through time-restricted feeding (TRF) such as the 16:8 protocol, alternate-day fasting (ADF), or the 5:2 regimen—individuals can artificially induce metabolic shifting. When exogenous glucose and hepatic glycogen stores are depleted, typically occurring between 12 to 36 hours depending on antecedent physical activity and baseline hepatic reserve, the human body undergoes a profound endocrine reorganisation. Insulin concentrations plummet, relieving the allosteric inhibition on hormone-sensitive lipase (HSL) and initiating systemic lipolysis. Concurrently, hepatic ketogenesis increases, elevating circulating $\beta$-hydroxybutyrate ($\beta$HB) levels. This shift is not solely energetic; $\beta$HB acts as a potent endogenous histone deacetylase (HDAC) inhibitor and signalling metabolite, upregulating stress-resistance genes and dampening chronic, low-grade systemic inflammation via the suppression of the NLRP3 inflammasome.

Crucially, the biological downstream effects of intermittent fasting extend deep into cellular housekeeping. Nutrient-sensing networks—specifically the downregulation of the mechanistic target of rapamycin (mTOR) pathway and the simultaneous upregulation of 5'-adenosine monophosphate-activated protein kinase (AMPK)—act as the primary molecular switches governing autophagic flux. When AMPK senses a high AMP/ATP ratio, it directly phosphorylates and activates Un-5-like kinase 1 (ULK1), initiating the nucleation of the phagophore. This process allows the cell to systematically degrade dysfunctional mitochondria (mitophagy), clear misfolded protein aggregates, and eliminate intracellular pathogens, thereby mitigating the accumulation of cellular senescence that underpins modern non-communicable diseases. For the British populace facing escalating burdens of type 2 diabetes, cardiovascular pathologies, and neurodegenerative decline, integrating rigorous, evidence-based fasting protocols offers a biochemically precise methodology to restore homeostatic control, reactivate metabolic plasticity, and optimize foundational biological longevity.

The Biology — How It Works

To truly comprehend the physiological efficacy of intermittent fasting protocols within the framework of the modern British lifestyle, one must move past superficial caloric restriction models and examine the evolutionary-conserved cellular switches governed by nutrient-sensing pathways. Homo sapiens evolved under conditions of cyclic nutrient scarcity, developing sophisticated metabolic adaptations that are systematically suppressed by the contemporary UK diet—characterised by a high-frequency, carbohydrate-dense intake pattern. At the molecular core of intermittent fasting lies the transition from a glucose-dependent state to metabolic flexibility: the capacity of the organism to seamlessly pivot between exogenous carbohydrate oxidation and endogenous lipid mobilisation.

When an individual initiates a fasting window—such as the popular 16:8 regimen or alternate-day protocols—a predictable cascade of neuroendocrine and cellular adjustments occurs. As circulating glucose and hepatic glycogen stores are depleted, typically between 12 and 18 hours post-prandial, insulin secretion plummets. Insulin, an anabolic peptide hormone, acts as a primary gatekeeper; its chronic elevation in the standard British diet continuously suppresses lipolysis and downregulates autophagic machinery. The reduction in the insulin-to-glucagon ratio removes this suppression, catalysing hormone-sensitive lipase (HSL) within adipocytes. Consequently, triglycerides are hydrolysed into non-esterified fatty acids (NEFAs) and glycerol, which are transported to the liver and skeletal muscle to be beta-oxidised into ketone bodies, predominantly acetoacetate and $\beta$-hydroxybutyrate ($\beta$HB).

Beyond serving as an efficient alternative substrate for cerebral and myocardial tissue, $\beta$HB functions as an epigenetic modifier and endogenous signalling molecule. Research indexed in PubMed demonstrates that $\beta$HB acts as a histone deacetylase (HDAC) inhibitor, upregulating the transcription of stress-resistance genes, including superoxide dismutase (SOD) and catalase, which mitigate oxidative stress. Concurrently, the nutrient-sensing network experiences a profound polarization: mammalian target of rapamycin complex 1 (mTORC1), the master regulator of growth and cellular proliferation, is deactivated due to low intracellular amino acid concentrations, particularly leucine and methionine.

Conversely, this metabolic paucity upregulates AMP-activated protein kinase (AMPK), the cell’s primary low-energy sensor. When the AMP-to-ATP ratio rises, AMPK activates uncoordinated 5-like kinase 1 (ULK1) and phosphorylates transcription factor EB (TFEB), initiating macroautophagy—hereafter referred to simply as autophagy. This catabolic clearance mechanism is vital for cellular homeostasis; it systematically sequesters damaged organelles, misfolded proteins (such as amyloid-beta aggregates), and intracellular pathogens into double-membraned vesicles called autophagosomes, which fuse with lysosomes for enzymatic degradation and recycling.

In a population facing rising trajectories of metabolic syndrome, type 2 diabetes, and neurodegenerative pathologies, restoring this ancient biochemical rhythm is not merely a lifestyle modification; it is a biological necessity. By periodically removing the constant influx of exogenous macronutrients, intermittent fasting protocols force cellular housekeeping, re-establish insulin sensitivity, and recalibrate mitochondrial density. At INNERSTANDIN, we recognise that bridging the gap between genomic evolutionary expectations and twenty-first-century British nutritional habits requires an unyielding adherence to these fundamental molecular truths.

Mechanisms at the Cellular Level

At the molecular tier, intermittent fasting (IF) acts as a profound thermodynamic and signalling reset, dismantling the perpetual-storage paradigm dictated by the standard modern British diet. When transitioning from a state of constant nutrient availability to metabolic restriction, the human cellular machinery undergoes a strict bioenergetic triage. Research indexed across PubMed highlights that extending the postprandial window beyond the standard glycogenolytic phase forces a fundamental shift in systemic cofactors, primarily downregulating the mechanistic target of rapamycin (mTOR)—a master anabolic kinase that senses intracellular amino acid sufficiency, growth factors, and energy status. By suppressing mTOR complexes 1 and 2, IF removes the molecular brake on catabolic clearance pathways, most notably macroautophagy.

This upregulation of macroautophagy is not merely a passive cleanup operation; it is an evolutionarily conserved recycling protocol. As circulating glucose and insulin titers recede, the AMP-activated protein kinase (AMPK) pathway senses the corresponding drop in the intracellular ATP-to-AMP ratio. AMPK functions as the cellular fuel gauge, phosphorylating and activating downstream targets such as Unc-51-like kinase 1 (ULK1) and the transcription factor EB (TFEB), which translocates to the nucleus to drive the biogenesis of lysosomes and autophagosomes. Damaged mitochondria, dysfunctional proteins, and intracellular pathogens are subsequently sequestered, degraded, and broken down into base amino acids and fatty acids. This mitochondrial quality control—mitophagy—is vital for mitigating oxidative stress within the high-demand tissues of the British populace, who are frequently exposed to urban particulate pollution and processed dietary xenobiotics.

Simultaneously, the transcriptional landscape experiences a sweeping epigenetic reorganisation. Fasting-induced nutrient deprivation elevates intracellular nicotinamide adenine dinucleotide (NAD+) levels, acting as a direct substrate for the sirtuin family of class III histone deacetylases, particularly SIRT1 and SIRT3. These enzymes modulate chromatin structure and deacetylate key transcription factors, including peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). The activation of PGC-1α orchestrates mitochondrial biogenesis, enhances fatty acid oxidation, and upregulates endogenous antioxidant defences such as superoxide dismutase (SOD) and catalase via the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway.

Furthermore, this metabolic recalibration profoundly alters systemic neuroendocrine signaling. The attenuation of chronic hyperinsulinaemia enhances peripheral insulin receptor sensitivity, facilitating the clearance of advanced glycation end-products (AGEs) and mitigating systemic low-grade inflammation—a hallmark of contemporary lifestyle-induced pathologies documented extensively in The Lancet. By systematically oscillating between fuel-sensing states, the cell transitions from an unchecked proliferative and storage-biased phenotype to a highly resilient, proteostatically stable state. At INNERSTANDIN, we recognise that mastering these cellular checkpoints is the foundational prerequisite for achieving true metabolic flexibility, liberating human physiology from the metabolic inflexibility hardwired into modern dietary patterns.

Environmental Threats and Biological Disruptors

The modern British biome does not exist in a vacuum; it is relentlessly bombarded by anthropogenic disruptors that systematically erode metabolic flexibility and blunt the cellular efficacy of intermittent fasting protocols. Urban environments across the United Kingdom expose populations to a complex matrix of endocrine-disrupting chemicals (EDCs), omnipresent artificial lighting, and ultra-processed foods (UPFs) engineered for hyper-palatability. These variables converge at the molecular level, impairing the natural signaling cascades—specifically AMP-activated protein kinase (AMPK) activation and mammalian target of rapamycin (mTOR) inhibition—that are fundamentally required for fasting-induced autophagy and metabolic recalibration.

Epidemiological data published in The Lancet underscore how modern dietary architectures dominated by UPFs—which constitute over 50% of the average British caloric intake—disrupt the gut-liver axis. Chronic exposure to dietary emulsifiers, synthetic preservatives, and refined fructans degrades the mucosal layer of the large intestine, precipitating low-grade systemic inflammation mediated by lipopolysaccharides (LPS). When intermittent fasting protocols are initiated against this backdrop of chronic endotoxemia, the expected upregulation of hepatic sirtuins (specifically SIRT1) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1$\alpha$) is severely blunted. The metabolic machinery, clogged by xenobiotic interference, struggles to transition efficiently from exogenous glucose oxidation to endogenous fatty acid beta-oxidation and ketogenesis.

Furthermore, environmental pollutants act as potent obesogens that accumulate within adipose tissue depots. Persistent organic pollutants (POPs) and phthalates, heavily documented in urban UK air and water quality reports, disrupt nuclear receptors such as the peroxisome proliferator-activated receptor gamma (PPAR$\gamma$). During extended fasting windows—such as the 16:8 or 20:4 regimens—lipolysis releases these stored xenobiotics back into the systemic circulation. Without robust phase II hepatic detoxification pathways, these circulating lipophilic toxins create oxidative stress, temporarily elevating reactive oxygen species (ROS) and triggering nuclear factor erythroid 2-related factor 2 (Nrf2) pathways. While acute Nrf2 activation is hormetic and protective, chronic xenobiotic stress combined with erratic fasting habits accelerates cellular senescence rather than clearing it through macroautophagy.

Chronodisruption further exacerbates these biological hurdles. The pervasive urban glow and late-night digital engagement suppress nocturnal melatonin synthesis, shifting the central circadian pacemaker in the suprachiasmatic nucleus out of alignment with peripheral clocks in the pancreas and liver. As demonstrated in translational chronobiology models featured on PubMed, circadian misalignment directly impairs glucose tolerance and blunts insulin sensitivity during the feeding window. Consequently, even a meticulously timed intermittent fasting protocol fails to achieve optimal metabolic partitioning if the subject's circadian architecture is compromised by modern lighting and shift-work patterns typical of the contemporary British economy.

At INNERSTANDIN, our analysis dictates that deploying fasting protocols as a standalone intervention is insufficient. To truly optimise metabolic flexibility, practitioners must actively mitigate environmental interferences by prioritising organic, whole-food nutritional inputs to protect the microbiome, enhancing home filtration to reduce EDC load, and strictly aligning eating windows with natural solar photoperiods to restore physiological harmony.

The Cascade: From Exposure to Disease

Chronic metabolic dysfunction within the contemporary British populace is fundamentally underpinned by relentless nutrient signalling, driven by the ubiquitous availability of ultra-processed foods and an entrenched cultural paradigm of frequent hyperphagia. At the molecular level, continuous caloric intake maintains the mammalian target of rapamycin (mTOR) in a state of perpetual activation while concurrently suppressing AMP-activated protein kinase (AMPK). This enzymatic imbalance disrupts baseline cellular homeostasis, culminating in a pathogenic cascade from environmental exposure to overt systemic disease. When exogenous substrates remain chronically abundant, the suppression of AMPK—the cell’s master energy sensor—halts the induction of autophagy. Consequently, damaged organelles, misfolded proteins, and senescent cells accumulate intracellularly, fostering a low-grade, systemic inflammatory state characterized by elevated circulating cytokines such as tumour necrosis factor-alpha (TNF-$\alpha$) and interleukin-6 (IL-6).

Epidemiological data from the UK Biobank consistently correlate this uninterrupted nutrient influx with the exponential rise of metabolic syndrome, type 2 diabetes mellitus, and non-alcoholic fatty liver disease (NAFLD). The pathophysiological trajectory begins at the hepatic level, where sustained hyperinsulinaemia downregulates LDL receptor expression and promotes de novo lipogenesis. As adipose tissue storage capacity reaches saturation, ectopic lipid deposition occurs within skeletal muscle and the myocardium, precipitating profound cellular insulin resistance. Furthermore, the absence of periodic fasting intervals prevents the physiological downregulation of the transcription factor forkhead box O (FOXO), impairing antioxidant defense mechanisms and accelerating cellular senescence across vascular endothelia.

Intermittent fasting protocols—specifically time-restricted feeding (TRF) and alternate-day fasting regimens—interrupt this destructive cascade by artificially inducing metabolic windows of nutrient deprivation. Peer-reviewed translational studies indexed in PubMed demonstrate that a sustained fasting window of sixteen hours or greater transitions the human organism from glucose dependency to hepatic fat oxidation. This metabolic shift reduces circulating insulin concentrations, thereby alleviating the chronic suppression on AMPK and unblocking the initiation complex of macroautophagy, mediated by the ULK1 kinase pathway. Within UK clinical contexts, implementing structured fasting protocols has been shown to restore circadian metabolic rhythms, enhance mitochondrial respiration efficiency, and attenuate systemic inflammation. By resetting the primary molecular switches governing energy sensing and cellular repair, intermittent fasting effectively reverses the foundational pathophysiology of metabolic inflexibility, offering a targeted, evidence-led countermeasure to the lifestyle-induced disease burdens documented across the British health landscape.

What the Mainstream Narrative Omits

Popular health media frequently reduces intermittent fasting to a simple energetic ledger: a temporal restriction strategy designed merely to curtail caloric intake through the reduction of feeding windows. This hyper-simplistic narrative fundamentally misrepresents the evolutionary endocrinology at play, ignoring the profound molecular signalling cascades triggered specifically by the absence of exogenous substrates. When we examine the biochemical reality documented in literature from repositories such as PubMed and The Lancet, it becomes glaringly apparent that fasting is not merely about energy balance; it is an evolutionary trigger designed to upregulate cellular repair mechanisms that remain perpetually suppressed in the continuously fed state characteristic of the modern British diet.

The primary oversight in mainstream discourse is the profound underestimation of metabolic flexibility—the cellular capacity to seamlessly transition between lipid oxidation and carbohydrate combustion. Chronic, ad-libitum consumption of ultra-processed foods, heavily embedded in contemporary UK food culture, downregulates Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and impairs mitochondrial biogenesis. True intermittent fasting protocols do not just clear out glycogen stores; they induce a systemic metabolic pivot. As hepatic glycogen is depleted typically around the 14-to-18-hour mark, the organism shifts from glucose-dependent glycolysis to hepatic ketogenesis. Circulating levels of beta-hydroxybutyrate (BHB) rise, acting not merely as an alternative energy substrate for the myocardium and central nervous system, but functioning crucially as an endogenous histone deacetylase (HDAC) inhibitor. This epigenetic shift upregulates stress-resistance genes and neurotrophic factors like Brain-Derived Neurotrophic Factor (BDNF), pathways entirely overlooked by calorie-counting paradigms.

Furthermore, the mainstream media consistently conflates simple weight loss with the activation of macro-autophagic flux. Autophagy—the lysosomal degradation and recycling of damaged cellular organelles and misfolded proteins—is heavily suppressed by the constant presence of circulating insulin and amino acids, particularly leucine, which activates the mechanistic target of rapamycin complex 1 (mTORC1). When individuals adopt time-restricted feeding or alternate-day protocols, the resulting nadir in insulin and sustained downregulation of mTORC1 removes the biochemical brake on Unc-51 Like Autophagy Activating Kinase 1 (ULK1) initiation complexes. This initiates double-membrane phagophore formation, isolating dysfunctional mitochondria (mitophagy) and aggregated protein tau and amyloid species. This intracellular sanitation protocol operates independently of total energy deficit; yet, commercial wellness narratives rarely distinguish between aesthetic adiposity reduction and the systemic cytoprotective clearing of senescent cellular machinery.

At INNERSTANDIN, we recognise that evaluating fasting solely through the lens of weight management ignores its profound role as a genomic and proteomic reset. By omitting the nuances of chronobiology—specifically how fasting intervals realign peripheral clocks in hepatic, adipose, and musculoskeletal tissues with the central suprachiasmatic nucleus—popular discourse does a disservice to the physiological complexity of human metabolism. True optimization requires leveraging these deep-seated evolutionary pathways to restore cellular homeostasis, rather than treating temporal eating windows as a modern biohacking fad.

The UK Context

Examining the metabolic paradigm of the contemporary British populace reveals a striking biochemical friction between ancestral evolutionary design and 21st-century environmental programming. Data published in The Lancet underscores an escalating endemic of metabolic dysfunction across the UK, driven heavily by an omnipresent ultra-processed food architecture and a pervasive hyper-feeding chronotype. The standard British diet—traditionally anchored by carbohydrate-dense, frequent nutritional inputs—perpetuates a state of chronic hyperinsulinaemia. This constant endocrine signalling suppresses hepatic lipid oxidation and downregulates the cellular machinery responsible for metabolic switching. Consequently, the average UK citizen remains locked in a state of glucotoxic inflexibility, where mitochondria are chronically inundated with exogenous glucose, eroding the innate enzymatic capacity to oxidise endogenous adipose reserves.

To reverse this systemic metabolic stalling, Intermittent Fasting (IF) protocols act as a precise evolutionary catalyst. By imposing strategic temporal windows of nutrient deprivation—such as the 16:8 time-restricted feeding model or alternate-day fasting—British practitioners can effectively dismantle chronic insulin-mediated suppression. Once hepatic glycogen stores are depleted, typically at the 12-to-18-hour juncture depending on antecedent physical exertion and glycaemic load, the organism transitions from carbohydrate dependency to fat oxidation. Research indexed in PubMed highlights that this metabolic recalibration upregulates AMP-activated protein kinase (AMPK) while simultaneously inhibiting the mechanistic target of rapamycin (mTOR) pathway.

At INNERSTANDIN, our analysis of clinical trials demonstrates that this biochemical shift does far more than facilitate weight management; it fundamentally restores cellular autonomy. The downregulation of mTOR initiates robust autophagic clearance—the lysosomal degradation of damaged organelles, misfolded proteins, and senescent cells that otherwise accumulate under conditions of constant nutrient excess. Furthermore, shifting to ketone body production, specifically $\beta$-hydroxybutyrate, provides an exceptionally clean-burning mitochondrial substrate that enhances neurotrophic signalling and reduces systemic oxidative stress. For a population navigating the sedentary demands of modern British professional life, implementing structured fasting protocols is not merely a dietary modification; it is a biological necessity required to re-establish enzymatic resilience, clear metabolic debris, and rescue the mitochondria from the relentless oxidative burden of contemporary dietary habits.

Protective Measures and Recovery Protocols

While the upregulation of cellular clearance mechanisms and the transition toward metabolic flexibility induced by intermittent fasting protocols represent potent physiological adaptations, these interventions are not without biological cost. Prolonged caloric restriction and extended fasting windows—particularly when superimposed upon the chronically elevated cortisol profiles and high-stress parameters typical of the modern British lifestyle—can precipitate counterproductive neuroendocrine responses. Chronic energetic deficits, if mismanaged, risk triggering a compensatory downregulation of the hypothalamic-pituitary-thyroid (HPT) axis, marked by suppressed triiodothyronine (T3) levels and elevated reverse T3 (rT3), alongside disruptions to gonadotropin-releasing hormone (GnRH) pulsatility. Consequently, deploying intermittent fasting requires a sophisticated understanding of protective countermeasures and structured recovery protocols to prevent systemic downregulation and ensure cellular hormesis does not cross the threshold into chronocatalytic exhaustion.

To mitigate catabolic overdrive and preserve lean muscle mass during extended periods of nutrient deprivation, specific biochemical safeguards must be integrated into the protocol. Clinical investigations indexed in PubMed consistently demonstrate that maintaining adequate amino acid kinetics is paramount. The strategic deployment of exogenous essential amino acids (EAAs) or targeted supplementation with branched-chain amino acids (BCAAs)—specifically leucine—can stimulate the mechanistic target of rapamycin complex 1 (mTORC1) threshold just enough to prevent excessive myofibrillar proteolysis without entirely abrogating the autophagic flux induced by the fasted state. Furthermore, British populations, who notoriously suffer from high rates of subclinical micronutrient insufficiencies due to latitude-induced vitamin D deficits and agrarian soil depletion, must pay meticulous attention to electrolyte homeostasis. Extended fasting accelerates renal sodium excretion secondary to declines in insulin-mediated sodium reabsorption in the distal tubules. Unmitigated, this leads to secondary aldosteronism, lethargy, and cardiac arrhythmias. Protocol optimisation therefore mandates the supplementation of bioavailable sodium, potassium, and magnesium salts during the fasting window to maintain transmembrane potential and neuromuscular excitability.

Recovery and refeeding phases represent the most vulnerable window within any intermittent fasting architecture. The transition from catabolism to anabolism must be orchestrated with biochemical precision to prevent oxidative stress and systemic inflammation. Upon breaking an extended fast, the sudden influx of glucose can trigger a precipitous surge in insulin, which, in the presence of depleted intracellular magnesium and potassium stores, drives electrolytes intracellularly. This mechanism underpins the dangerous physiology of refeeding syndrome, characterised by acute hypophosphatemia and cardiovascular collapse. To circumvent this, initial refeeding must rely on low-glycaemic, nutrient-dense substrates coupled with high-quality dietary fats and easily digestible proteins, thereby blunting the insulin spike and allowing cellular machinery to re-establish homeostatic equilibrium gradually.

At INNERSTANDIN, our analysis of longitudinal data underscores that metabolic flexibility is not achieved through relentless deprivation, but through cyclical perturbation followed by robust recovery. Incorporating strategic "refeed" days—characterised by eucaloric carbohydrate intake—prevents leptin signalling collapse and restores thyroid hormone conversion rates. Ultimately, safeguarding the long-term efficacy of intermittent fasting demands an individualized, evidence-based approach that respects the delicate feedback loops governing human bioenergetics.

Summary: Key Takeaways

Rigorous interrogation of peer-reviewed literature indexed in PubMed and The Lancet demonstrates that intermittent fasting (IF) protocols act as a profound epigenetic catalyst, effectively counteracting the metabolic dysregulation endemic to the contemporary British lifestyle. By systematically transitioning the human organism from glucose dependency to hepatic fatty acid oxidation and ketogenesis, time-restricted eating upregulates peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and AMP-activated protein kinase (AMPK). This enzymatic cascade enhances mitochondrial biogenesis and elevates baseline metabolic flexibility. Concurrently, the downregulation of the mechanistic target of rapamycin (mTOR) and concurrent upregulation of unc-51-like autophagy activating kinase 1 (ULK1) stimulate targeted macroautophagy. This intracellular recycling clears dysfunctional organelles and misfolded proteins, mitigating systemic low-grade inflammation—a primary driver of cardiometabolic pathologies prevalent across the UK populace. Ultimately, aligning nutrient timing with intrinsic circadian oscillations restores hormonal homeostasis, optimising insulin sensitivity and cellular resilience independent of caloric restriction alone.